Original Article

Chlamydia Screening in a Metropolitan Atlanta Primary Care Clinic

Authors: Natalia V. Oster, RN, MPH, Richard Rothenberg, MD, MPH, Carol A. McPhillips-Tangum, MPH, Julie Gazmararian, PHD, MPH, Adele L. Franks, MD

Abstract

Background Chlamydia is the most commonly reported infectious disease in the United States, yet many women at risk for chlamydia infection are not being tested. Methods We conducted a chlamydia screening study (Phase I) and retrospective medical chart review (Phase II) of 199 women from 16 to 40 years of age attending a primary care clinic in metropolitan Atlanta. Results Two (1%) of the 199 study participants tested positive for chlamydia during Phase I. Phase II medical chart reviews indicated that only 35% of study participants had been tested for chlamydia at least once in the previous 15 months. Three of these individuals tested positive, yielding a prevalence of 5.6%. All infections occurred in women 30 years of age or younger. Conclusion The results suggest that chlamydia screening is low and that recommended guidelines are not being followed. Strategies are needed to increase the rates of screening and adherence to these guidelines to ensure that chlamydia is detected before complications occur.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 1997. Atlanta, GA, U.S. Department of Health and Human Services, Division of STD Prevention.
 
2. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease: Trends and projections, 1983 through 2000. JAMA 1991; 266: 2565–2569.
 
3. Institute of Medicine. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC, National Academy Press, 1996.
 
4. Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections, United States 1995. MMWR Morb Mortal Wkly Rep 1997; 46: 193–198.
 
5. Centers for Disease Control and Prevention. Recommendations for the prevention and management ofChlamydia trachomatis infections, 1993. MMWR Recomm Rep 1993; 42(RR-12): 1–35.
 
6. Centers for Disease Control and Prevention. Chlamydia in the United States. Atlanta, GA, U.S. Department of Health and Human Services, National Center for HIV, STD and TB Prevention. Available at: http://www.cdc.gov/nchstp/dstd/Fact_Sheets/chlamydia_facts.htm. Accessed July 11, 2003.
 
7. Cook RL, Wiesenfeld HC, Ashton MR, et al. Barriers to screening sexually active adolescent women for chlamydia: A survey of primary care physicians. J Adolesc Health 2001; 28: 204–210.
 
8. Burstein GL, Snyder MH, Conley D, et al. Adolescent chlamydia testing practices and diagnosed infections in a large managed care organization. Sex Transm Dis 2001; 28: 477–483.
 
9. Mangione-Smith R, O'Leary J, McGlynn EA. Health and cost benefits of chlamydia screening in young women. Sex Transm Dis 1999; 26: 309–316.
 
10. National Committee for Quality Assurance. The State of Managed Care Quality, 2001: Chlamydia Screening in Women. Available at: http://www.ncqa.org/somc2001/chlamydia/somc_2001_chl.html. Accessed May 2, 2003.
 
11. Masse R, Laperriere H, Rousseau H, et al. Chlamydia trachomatis cervical infection: Prevalence and determinants among women presenting for routine gynecologic examination. CMAJ 1991; 145: 953–961.
 
12. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160–184.
 
13. Howell MR, Quinn TC, Brathwaite W, et al. Screening women for Chlamydia trachomatis in family planning clinics: The cost-effectiveness of DNA amplifications assays. Sex Transm Dis 1998; 25: 108–117.